SRAX Inc EBITDA margin
Mi az SRAX Inc EBITDA margin?
A EBITDA margin az SRAX Inc - -465.79%
Mi a EBITDA margin meghatározása?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin a Communication Services szektor a NASDAQ-on cégekben a SRAX Inc -hoz képest
Mit csinál SRAX Inc?
digital marketing and data management platform delivering the tools to unlock the value of data across marketing channels. srax leads innovation in the digital advertising and consumer data market by identifying brands and content owners’ core consumers and discovering new and measurable opportunities to amplify their campaign performance.
ebitda margin -hoz hasonló cégek SRAX Inc
- Sangamo Therapeutics Inc nak EBITDA margin -474.14% van
- Xinyang Maojian nak EBITDA margin -471.45% van
- WANdisco Plc nak EBITDA margin -470.42% van
- RYU Apparel nak EBITDA margin -468.27% van
- Barra Resources nak EBITDA margin -466.28% van
- Fiduciary/Claymore Infrastructure Fund nak EBITDA margin -466.20% van
- SRAX Inc nak EBITDA margin -465.79% van
- Xtract One Technolgies Inc nak EBITDA margin -464.36% van
- Spruce Biosciences nak EBITDA margin -462.16% van
- Sage Therapeutics Inc nak EBITDA margin -460.83% van
- Arcimoto Inc nak EBITDA margin -460.40% van
- Canopy Rivers nak EBITDA margin -458.36% van
- SenesTech Inc nak EBITDA margin -457.36% van